The scientific programme for FIGO Montréal 2027 is shaped by the Congress theme: Advancing innovation, equity and excellence in women’s health. Across all scientific streams, delegates will explore the latest evidence, emerging technologies and best practices that are transforming obstetrics and gynaecology worldwide. The programme is designed to encourage multidisciplinary collaboration, address global priorities and support equitable access to high-quality care for women and girls in every setting.
Together, the scientific streams reflect FIGO’s commitment to sharing knowledge, fostering collaboration and improving health outcomes through evidence-based practice and innovation.
| Stream name | Stream topics |
|---|---|
|
Maternal fetal medicine
Leader: Professor Liona Poon, Hong Kong
|
|
|
Clinical obstetrics
Leader: Professor Fionnuala McAuliffe, Ireland
|
|
|
Gynaecology
Leader: Dr Megan Wasson, USA
|
|
|
Sexual and reproductive health and rights
Leader: Dr Aparna Sridhar, USA
|
|
|
Reproductive medicine
Leader: Professor Anis Feki, Tunisia / Switzerland
|
|
|
Women’s cancer
Leader: Professor Etsuko Miyagi, Japan
|
|
|
Endocrinology
Leader: Professor Basil Tarlatzis, Greece
|
|
|
Pain
Leader: Dr Juan Diego Villegas-Echeverri, Colombia
|
Anaemia
Leader: Dr Hema Divakar, India
|
Obesity
Leader: Professor Cynthia Maxwell, Canada
|
|
Advocacy and health systems strengthening
|
||
As of 23 June 2026
1.1 Prenatal diagnosis, genetics, therapy and surgery
1.2 Nutrition in pregnancy and breastfeeding
1.3 Ultrasound in pregnancy
1.4 Infections, vaccination and anaemia in pregnancy
1.5 Preeclampsia and hypertensive disorders of pregnancy, including long-term health
2.1 Obstetric emergencies, including post-partum haemorrhage (PPH) and sepsis
2.2 Operative obstetrics, including c-section, operative vaginal delivery and perineal trauma
2.3 Antenatal, postnatal and neonatal care
2.4 Midwifery care
2.5 Preterm birth and stillbirth
2.6 Maternal mortality
3.1 Urogynaecology, including pelvic organ prolapse and incontinence
3.2 Chronic pelvic pain
3.3 Fibroids, endometriosis and adenomyosis
3.4 Minimal access surgery, laparoscopy, robotics and hysteroscopy
3.5 Fistula prevention and treatment
3.6 Breast disease
3.7 Gender-affirming care
4.1 Contraception and family planning
4.2 Abortion care
4.3 Adolescent health
4.4 Sexual health and STI/HIV prevention
4.5 Women facing crisis
4.6 Female genital mutilation
5.1 Fertility
5.2 Innovation in reproductive technology
5.3 Environmental challenges
5.4 Legal and ethical aspects of human reproduction
5.5 Endometriosis and adenomyosis
6.1 Cervical cancer and HPV
6.2 Vaginal and vulvar cancers
6.3 Ovarian and uterine cancers
6.4 Breast cancer
6.5 Genetics, screening and prevention
6.6 Diagnosis and management of gynaecological malignancies
7.1 Menstrual health
7.2 Menopause and perimenopause
7.3 Diabetes
7.4 PCOS/PMOS
7.5 Nutrition
7.6 Obesity
